This is a type of cancer that starts in the nasopharynx, which is the upper part of the throat behind your nose. It's a serious condition, and it's more common in some parts of the world. It can sometimes cause symptoms like nosebleeds, hearing loss, or a lump in the neck.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Nasopharyngeal Cancer?
Nasopharyngeal cancer, also called nasopharyngeal carcinoma or NPC, is a cancer that starts in the lining of the nasopharynx: the upper part of the throat, tucked behind the nose and above the soft palate. It is grouped with head and neck cancers, but it behaves differently from most throat cancers in its causes, its treatment and the way it is found. Because the nasopharynx is hidden and sits next to the openings of the ear tubes, the nasal passages and the base of the skull, early cancer there often causes vague or no symptoms. The most common first sign is a painless lump in the neck, usually a lymph node the cancer has spread to. Other signs include fullness, ringing or hearing loss in one ear, a stuffy or blocked nose, nosebleeds and headaches. As the cancer grows toward nearby nerves, it can cause facial numbness, double vision or trouble opening the mouth. These symptoms are much more often caused by common problems, which is one reason NPC is frequently found after it has spread to the neck.
Infection with Epstein-Barr virus (EBV), the common virus that causes mononucleosis, plays a central role in most cases. Nearly everyone catches EBV at some point and very few develop this cancer, so the virus is necessary in many cases but not enough on its own. Other factors appear to affect how the body handles the virus. NPC is uncommon in the United States but much more common in southern China, Southeast Asia, North Africa and the Arctic. Living in or having family roots in those regions raises risk, as does having a close relative with NPC. A diet high in salt-cured fish and meat, especially from childhood, is linked to higher risk, possibly because these foods contain cancer-promoting chemicals called nitrosamines. Tobacco smoke and heavy drinking are also associated with NPC. In rare cases, human papillomavirus (HPV) is involved. Men are affected more often than women, and in low-risk countries it is usually diagnosed after age 50. Having a risk factor does not mean someone will develop NPC, and many people who do have no obvious one.
An ear, nose and throat specialist usually starts by looking directly at the nasopharynx with a nasopharyngoscope, a thin, flexible, lighted tube passed through the nose. If an area looks abnormal, a small tissue sample (biopsy) is taken and examined under a microscope. The biopsy is what confirms the diagnosis. When the first sign is a neck lump, a needle sample from the lump may show cancer cells that carry EBV, which points to the nasopharynx as the source. Once cancer is confirmed, imaging shows how far it extends. An MRI gives a detailed view of the skull base and nearby nerves, and a PET-CT scan looks for spread to lymph nodes or distant organs such as the lungs, bones or liver. A blood test can measure EBV DNA from the tumor; higher levels before treatment, and levels that stay high afterward, are linked to a worse outlook, so the test helps with planning and follow-up. Hearing tests, dental evaluation and blood work are usually done before treatment as a baseline. The results are combined into a stage from I to IV. Stage I is confined to the nasopharynx and nearby areas; stages II and III involve lymph nodes in the neck or spread into surrounding tissue; stage IVA reaches structures such as the brain or cranial nerves or very large or low neck nodes; and stage IVB means spread to distant parts of the body.
Radiation therapy is the backbone of treatment, because the nasopharynx is deep in the head and very hard to reach with surgery. It is usually given as intensity-modulated radiation therapy (IMRT), which shapes the beams around the tumor to spare nearby tissue; IMRT is less likely than older techniques to cause permanent dry mouth. A course typically runs once a day, five days a week, for about 6 to 7 weeks, with a fitted mesh mask holding the head still. Because the area is surrounded by the eyes, ears, brain and salivary glands, treatment at a center experienced with NPC matters. For stage I disease, radiation alone to the tumor and neck lymph nodes is usually enough. For stages II through IVA, most people receive chemoradiation, meaning chemotherapy (most often cisplatin) given during radiation, which in most studies helps people live longer than radiation alone. For more advanced disease, chemotherapy is often given first (induction chemotherapy, such as gemcitabine with cisplatin) or after chemoradiation. Adding chemotherapy also adds side effects that can weigh on quality of life during treatment, so the expected benefit for a given stage is part of the discussion. When NPC has spread to distant organs or returns after treatment, chemotherapy is combined with immunotherapy. Toripalimab (Loqtorzi), a PD-1 inhibitor that helps the immune system recognize cancer cells, is approved in the US with cisplatin and gemcitabine as a first treatment for metastatic or recurrent disease, and on its own after chemotherapy stops working. Its main trade-off is that the immune system can occasionally attack healthy organs. Surgery is used mainly when cancer remains in neck lymph nodes after treatment or comes back in a limited area. A dental check and any needed repairs before radiation are an important part of preparing, since radiation dries the mouth and makes existing tooth problems worse and harder to fix later.
Many people with NPC are cured, particularly when the cancer has not spread beyond the head and neck. In US data, about 86% of people with cancer confined to the nasopharynx, 79% with spread to nearby tissue or lymph nodes, and 40% with distant spread were alive five years after diagnosis, relative to people without the cancer. These figures come from people treated years ago and describe groups, not any one person. The treatment period is demanding. By the later weeks of radiation, mouth and throat soreness, loss of taste, thick saliva and tiredness can make eating and talking hard, and some people need a temporary feeding tube to keep up nutrition. Most of these effects ease over the weeks and months after treatment ends. Others can last or appear years later: lasting dry mouth and tooth decay, hearing loss, stiffness of the jaw, swallowing problems, an underactive thyroid or pituitary gland, and, less often, changes in vision, nerves or memory. Many of these can be managed with dental care, hormone replacement, hearing aids and speech and swallowing therapy. Follow-up continues for years, with head and neck exams, imaging when needed, sometimes EBV DNA blood tests, regular thyroid blood tests and frequent dental visits. Survivors also have a higher chance of a second cancer in the head and neck region, which these visits help catch. Stopping smoking improves the results of treatment and lowers the chance of the cancer returning.
See a doctor, ideally an ear, nose and throat specialist, if a neck lump lasts more than a few weeks, if one ear feels blocked or loses hearing without a cold, or if nasal blockage or nosebleeds keep coming back. This matters even more for people with family roots in southern China, Southeast Asia or North Africa, or with a relative who had NPC. During and after treatment, contact the care team promptly about new symptoms such as headaches, facial numbness, double vision, a new neck lump or weight loss from difficulty eating. People receiving immunotherapy should report any new side effect right away, since immune reactions are easier to treat when caught early.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Nasopharyngeal Cancer is like, what's helped you, or ask the community a question.